Download Citation
Article Source:
A Multicenter, Randomized Clinical Trial Comparing the Three-Weekly Docetaxel Regimen plus Prednisone versus Mitoxantone plus Prednisone for Chinese Patients with Metastatic Castration Refractory Prostate Cancer
Zhou T,
Zeng Sx,
Ye Dw,
Wei Q,
Zhang X,
et al.
(2015)
A Multicenter, Randomized Clinical Trial Comparing the Three-Weekly Docetaxel Regimen plus Prednisone versus Mitoxantone plus Prednisone for Chinese Patients with Metastatic Castration Refractory Prostate Cancer.
PLOS ONE 10(1): e0117002.
https://doi.org/10.1371/journal.pone.0117002